Does RIPRETINIB Cause Skin hypertrophy? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Skin hypertrophy have been filed in association with RIPRETINIB (QINLOCK). This represents 0.4% of all adverse event reports for RIPRETINIB.
17
Reports of Skin hypertrophy with RIPRETINIB
0.4%
of all RIPRETINIB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Skin hypertrophy From RIPRETINIB?
Of the 17 reports, 1 (5.9%) resulted in death, 3 (17.6%) required hospitalization.
Is Skin hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIPRETINIB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does RIPRETINIB Cause?
Fatigue (582)
Alopecia (517)
Extra dose administered (357)
Death (356)
Underdose (345)
Nausea (292)
Drug ineffective (291)
Disease progression (290)
Hospitalisation (280)
Neoplasm progression (263)
What Other Drugs Cause Skin hypertrophy?
DUPILUMAB (149)
SECUKINUMAB (134)
ADALIMUMAB (105)
ETANERCEPT (48)
METHOTREXATE (42)
RITUXIMAB (41)
TACROLIMUS (40)
OMALIZUMAB (35)
PREDNISOLONE (35)
SUNITINIB MALATE (32)
Which RIPRETINIB Alternatives Have Lower Skin hypertrophy Risk?
RIPRETINIB vs RISANKIZUMAB
RIPRETINIB vs RISANKIZUMAB-RZAA
RIPRETINIB vs RISDIPLAM
RIPRETINIB vs RISEDRONATE
RIPRETINIB vs RISEDRONIC ACID